# Safety and Efficacy of Empagliflozin in GSD1b Patients With Neutropenia

> **NCT04930627** · PHASE2 · UNKNOWN · sponsor: **Children's Memorial Health Institute, Poland** · enrollment: 20 (estimated)

## Conditions studied

- Glucose 6 Phosphatase Deficiency

## Interventions

- **DRUG:** Empagliflozin

## Key facts

- **NCT ID:** NCT04930627
- **Lead sponsor:** Children's Memorial Health Institute, Poland
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07
- **Primary completion:** 2024-06
- **Final completion:** 2025-03
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2021-06-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04930627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04930627, "Safety and Efficacy of Empagliflozin in GSD1b Patients With Neutropenia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04930627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*